Investors

Introduction

Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company primarily focused on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated delivery system (LUNAR™) and UNA Oligomer chemistry technologies.

The Investor Relations section is designed to provide easy access to company information.

NASDAQ: ARCT

$ 8.19

4:00 PM | Dec 15, 2017
-$0.32
(3.76%)

Day High: 8.68
Day Low:  8.19
Volume:    21,617
Delayed ~20 min., by eSignal.